|
|
|
|
Leading experts discuss the evolving landscape of viral vector integrity testing. Gain perspective on analytical innovations that support consistent, high-quality outcomes in the fast-moving field of gene therapy.
|
|
|
|
|
Genome integrity is a foundation for helping achieve gene therapy safety. This article highlights new strategies to evaluate AAV genomes, ensuring vectors meet the rigorous standards required for clinical success.
|
|
|
|
|
Explore how duplex dPCR provides absolute quantification of both AAV genomes and gene inserts in a single run. This approach enables deeper insights into vector quality and simplifies workflows for researchers advancing gene therapy programs.
|
|
|
|
|
Discover how CGT-specific dPCR assays enable accurate quantification and qualification of AAV vectors. Purpose-designed tools streamline quality control and strengthen confidence in therapeutic development decisions.
|
|
|
|
|
Reliable assessment of AAV DNA integrity is vital for helping develop safe and effective therapies. Learn how dPCR offers a sensitive and precise method for monitoring genome stability across development and manufacturing pipelines.
|
|
|
